Fingerprint Dive into the research topics where Investigational Cancer Therapeutics is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    223-Radium for metastatic osteosarcoma: Combination therapy with other agents and external beam radiotherapy

    Anderson, P., Scott, J., Parsai, S., Zahler, S., Worley, S., Shrikanthan, S., Subbiah, V. & Murphy, E., Apr 16 2020, In : ESMO Open. 5, 2, e000635.

    Research output: Contribution to journalArticle

    Open Access
  • Advances in targeting RET-dependent cancers

    Subbiah, V. & Cote, G. J., Apr 2020, In : Cancer discovery. 10, 4, p. 498-505 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors

    Naing, A., Gainor, J. F., Gelderblom, H., Forde, P. M., Butler, M. O., Lin, C. C., Sharma, S., Ochoa De Olza, M., Varga, A., Taylor, M., Schellens, J. H. M., Wu, H., Sun, H., Silva, A. P., Faris, J., Mataraza, J., Cameron, S. & Bauer, T. M., Mar 15 2020, In : Journal for immunotherapy of cancer. 8, 1, e000530.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations